Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease
Alka A. Potdar, Shishir Dube, Takeo Naito, Katherine Li, Gregory J. Botwin, Talin Haritunians, Dalin Li, David Casero, Shaohong Yang, Janine Bilsborough, Jacqueline Perrigoue, Lee A. Denson, Mark J. Daly, Stephan R. Targan, Phillip Fleshner, Jonathan Braun, Subra Kugathasan, Thaddeus S. Stappenbeck, Dermot McGovern
Topics & Concepts
MedicineInflammatory bowel diseaseInflammationDiseaseCytokineImmunologyGastroenterologyInternal medicineCOVID-19 Clinical Research StudiesRenin-Angiotensin System StudiesLong-Term Effects of COVID-19